Tekla Capital Management LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 170 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2019$561,000
-70.0%
37,700
-50.0%
0.02%
-69.7%
Q1 2019$1,871,000
+38.2%
75,4000.0%0.08%
+31.0%
Q4 2018$1,354,000
-38.8%
75,4000.0%0.06%
-27.5%
Q3 2018$2,214,000
-35.4%
75,4000.0%0.08%
-38.5%
Q2 2018$3,428,000
-13.9%
75,4000.0%0.13%
-16.1%
Q1 2018$3,981,000
-22.4%
75,4000.0%0.16%
-21.7%
Q4 2017$5,127,000
-17.5%
75,4000.0%0.20%
-10.8%
Q3 2017$6,213,000
-56.0%
75,400
-50.0%
0.22%
-57.6%
Q2 2017$14,119,000
+470533.3%
150,800
+295586.3%
0.52%
Q4 2014$3,000
-99.9%
51
-100.0%
0.00%
-100.0%
Q3 2014$4,720,000
+140.7%
104,051
+119.7%
0.22%
+22.8%
Q2 2014$1,961,000
-40.2%
47,3640.0%0.18%
-45.1%
Q1 2014$3,281,000
+66.7%
47,364
+45.0%
0.33%
+58.5%
Q4 2013$1,968,000
+42.7%
32,658
+44.0%
0.21%
+35.3%
Q3 2013$1,379,00022,6870.15%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2018
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders